Author name: Leonardo Arias

Competition for biotech and pharma employment picked up year over year and remains strong, according to BioSpace data. A survey late last year showed that 64% of employed/contract and 96% of unemployed respondents will actively look for work in 2026.

Fueled by advances in biomarkers, brain mapping, and AI, investment in neuro and CNS innovation shows no signs of slowing, even amid costly setbacks. BioSpace spoke to investors at JPM26 to get their take on recent bets in new therapies and neurotech.

Durante casi la mitad de la historia de la Tierra, respirar habría sido imposible para cualquier ser humano. La atmósfera primitiva carecía de oxígeno libre y estaba dominada por gases como el dióxido de carbono, el metano y el nitrógeno. Sin embargo, hace m …

The announcement comes one day before CEO Stephen Hemsley is set to testify on healthcare affordability in front of two congressional committees.

The healthcare fraud settlements under the False Claims Act last year more than tripled the amount from 2024.

Medtronic’s investment is contingent on Anteris completing a proposed $200 million public stock offering.

Cardiovascular was the only business unit to grow by double digits last year, helping to fuel the overall medical device business to top $33 billion.

Hollingshead, the former CEO of Insulet, will lead BVI as it uses a $1 billion financing to support its global eye care business.

Debra Osteen, the behavioral healthcare provider’s CEO from December 2018 through March 2022, will take up the post again effective immediately. The company’s stock has declined nearly 70% over the past year.

Reporting Q4 and full year earnings on Wednesday, J&J executives hailed growth across the healthcare giant’s portfolio while standing fast on its talc lawsuit and tariffs.